Michael Deem, the CEO at Man Labs which provides science-based anti-aging skincare to men joins Enterprise Radio.
Listen to host Eric Dye & guest Michael Deem discuss the following:
- How did you start this company; what made you think of doing this?
- Do men really need to worry about skincare?
- What is anti-aging skincare?
- What makes Man Labs’ anti-aging products stand out from competitors, tell us how the advanced formulas and specific ingredients like peptides that are most effective in Man Labs’ products work to reduce signs of aging?
- What mindset does an entrepreneur need?
TIP: Drawing from my experience as a VC, I wrote a series of posts on LinkedIn. One post was about the 4 legs of the startup stool: market, management, timing, and moat. We used to say at Khosla that a Seed stage company needs 3 legs, and a Series A stage company needs all 4. Think about how to build the legs of your stool as you build your company.
Michael Deem is CEO at Man Labs, which provides science-based anti-aging skincare to men. Man Labs’ evidence-based formulas address the unique challenges of men’s skin – testosterone, thicker skin, different oil production, damage from daily shaving, and years of neglect.
Michael Deem is also Managing Partner at Angeliki Fund, a physical and digital private equity infrastructure fund focused on dementia.
Michael is a former Entrepreneur in Residence at Khosla Ventures.
Michael Deem was the 3rd person and performed all the original engineering calculations at Ion Torrent Systems (sold to ThermoFisher for $2.3B in 2014). He was the 10th person and director of drug design at CuraGen ($100M IPO in 1998). He started the first `Synthetic Biology’ PhD program in the US.
He is also General Partner at SmartHealth Catalyzer. Michael’s intellectual bandwidth has benefited companies from a wide cross section of industries that include Life Sciences, Artificial Intelligence, Genomics, Data Science, Biotechnology, Energy, and Cancer Research.
Michael was Department Chair of Bioengineering at Rice University. In this capacity, he oversaw a department with 20 tenure track faculty, 5 non-tenure track faculty and instructors, 20 support and research staff, 200 undergraduate and 125 graduate students, and an annual research and operating budget of approximately $27 million. The faculty represent a broad range of disciplines in bioengineering: basic physics of biology and cancer, synthetic and systems biology, multimodal imaging, machine learning, tissue engineering, and biomaterials. The department is consistently ranked in the top 10 programs in Biomedical Engineering.
Michael is an active member of The National Association of Corporate Directors (NACD);
Michael completed a Postdoctoral Fellowship at Harvard University, earned a PhD from the University of California at Berkeley, and previously earned a Bachelor of Science with honor at the California Institute of Technology. He resides in the Houston area, enjoys driving fast cars at the F1 track in Austin, and keeping fit with 405 lb deadlifts.
Michael is an active member of The National Association of Corporate Directors (NACD), Board Leadership Fellow and Directorship Certified.
Website: https://manlabs.com
People also listened to this: Bridging Generations in Law: A Gen Z COO’s Vision for the Future of Legal Practice
Podcast: Play in new window | Download (Duration: 9:34 — 8.8MB) | Embed
Subscribe: Apple Podcasts | Spotify | iHeartRadio | TuneIn | | More